- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Astonea Labs has acquired a 25.74% equity stake in Damaira Pharmaceuticals Private Limited, a company specializing in the pharmaceutical business. This strategic investment, totaling INR 6.25 Crore and funded by IPO proceeds, aims to expand Astonea's presence in the pharma sector and bolster its operations. Damaira Pharmaceuticals reported a turnover of approximately INR 82.48 Crore for the most recent financial year and INR 25.16 Crore in the prior year. This acquisition is expected to generate long-term value and synergies, including expansion into new product segments and markets.